It covers the computational systems that we built to design and test a new family of chemical compounds in silico, synthesis of several prototypes, all the way through preliminary in vivo testing. It’s the culmination of about 4 yrs of work starting at SENS, finished at Underdog and involving collaborations with leading experts in Spain, Hungary, and China. Give it a look and let us know what you think!
Dr. Oki O’Connor talks with Phil Newman of Longevity.Technology about Cyclarity’s solution
Watch Cyclarity CEO of Scientific Affairs Dr. Oki O’Connor talk with Phil Newman of Longevity.Technology about Cyclarity’s elegant solution to one of the world’s biggest problems – atherosclerosis.